key: cord-0847928-i6jv5iba
authors: Darvall, Jai N.; Bellomo, Rinaldo; Bailey, Michael; Anstey, James; Pilcher, David
title: Long-term survival of critically ill patients stratified by pandemic triage categories: a retrospective cohort study
date: 2021-03-09
journal: Chest
DOI: 10.1016/j.chest.2021.03.002
sha: 40e66ac27efe979c19e3cf028d2037700ba2a54a
doc_id: 847928
cord_uid: i6jv5iba

Background The COVID-19 pandemic has led to unprecedented demand for ICU, with the need to triage admissions along with the development of ICU triage criteria. However, how these criteria relate to outcomes in patients already admitted to ICU is unknown, as is the incremental ICU capacity that triage of these patients might create given existing admission practices. Research Question What is the short and long-term survival of low vs. high priority patients for ICU admission according to current pandemic triage criteria? Study Design and Methods: We analysed prospectively collected registry data (2007-2018) in 23 ICUs in Victoria, Australia, with probabilistic linkage with death registries. After excluding elective surgery, we stratified admissions by existing ICU triage protocol prioritization as low (age >85 years, or severe chronic illness, or Sequential Organ Failure Assessment [SOFA] score = 0 or ≥12), medium (SOFA score 8-11) or high (SOFA score 1-7) priority. The primary outcome was long-term survival. Secondary outcomes were in-hospital mortality, ICU length of stay (LOS) and bed-day usage. Results We studied 126,687 ICU admissions. After five-years of follow up, 1093/3296 (33%, 95%CI 32%-34%) of “low-priority” patients aged >85 years or with severe chronic illness, and 86/332 (26%, 95%CI 24%-28%) with a SOFA score ≥12 were still alive. 63/290 [22%, 95% CI 17%-27%] of patients in these groups followed for 10 years were still alive. Together, low priority patients accounted for 27% of all ICU bed-days, and had lower in-hospital mortality (22%) than than high priority patients (28%). Among non-survivors, low-priority admissions had shorter ICU LOS than medium or high-priority admissions. Interpretation Current SOFA-score or age or severe comorbidity-based ICU pandemic triage protocols exclude patients with a close to 80% hospital survival, a >30% five-year survival and 27% of ICU bed-day use. These findings imply the need for stronger evidence-based ICU triage protocols.

The ongoing COVID-19 pandemic has led to unprecedented global demand for ICU resources, which has overwhelmed some hospital and critical care services. 1 This has led to challenging decisions about which patients (both COVID-19 and/or non-COVID-19) to admit to ICU, attracting significant media attention. 2 Similar recent outbreaks of communicable diseases including avian (H5N1) influenza, 3 severe acute respiratory syndrome (SARS), 4 and pandemic (H1N1) influenza, 5 have prompted the development of various ICU triage protocols.

Prior to this pandemic, the two most widely promulgated ICU triage protocols were developed separately in Minnesota, USA and Ontario, Canada, in 2006, 6, 7 and subsequently adapted in 2009 by the state government of New South Wales (NSW), Australia, to produce a mandatory ICU pandemic response policy directive. 8 These triage protocols involve a tiered response to ICU bed allocation, prioritising access on the basis of perceived survival prospects, including age, chronic comorbidities, and acute severity of illness scoring.

Moreover, the Sequential Organ Failure Assessment (SOFA) scoring system has also been used for this purpose. 9 In particular, the Ontario and NSW protocols rank the admission for patients with a SOFA score ≤7 as highest priority for ICU admission, SOFA score 8-11 as intermediate priority, and patients with age >85 years, or severe comorbidities, or SOFA score ≥12, as not for ICU admission. A 2012 Australian prospective evaluation study in eight ICUs simulating pandemic scenarios reported that application of these triage protocols might successfully increase ICU bed capacity by 23%. 10 More recently, however, the validity of this approach has been challenged. 11 12 Although extreme age, severe comorbid disease and higher SOFA scores correlate with worse outcomes in both COVID-19 and non-COVID-19 diseases, the ability of such scoring J o u r n a l P r e -p r o o f systems to discriminate survivors from non-survivors, and the relationship of comorbidities and SOFA scores to long-term outcomes is unclear. 13 In addition, given that overall median admission SOFA scores are low with COVID-19 critical illness, a proposed threshold of ≤ 7 has been challenged as unhelpful. [14] [15] [16] These observations have prompted a recent consensus group rapid guideline directive "We recommend against the use of the SOFA score for ICU triage of patients with COVID-19," 12 raising questions about the best approach to triage during high-level ICU demand situations. Importantly, however, this controversy remains heavily opinion-based, as there is limited literature on the hospital outcomes of patients (with or without COVID-19) who would be excluded from ICU under SOFA-based triage conditions. Perhaps even more importantly, the correlation of age, comorbidities and SOFA score thresholds proposed in triage protocols with short-term (hospital), mediumterm (5 years) and long-term (10 years) mortality is unknown.

Accordingly, we conducted a multicentre retrospective cohort study to examine the short, medium and long-term survival of patient groups who might receive tiered prioritization of access to ICU under current protocolized pandemic triage situations. Our aim was to describe the outcomes and resource utilisation of each group under normal working conditions, and thus to inform the validity of such categorisations. In particular, we hypothesized that the longer-term outcomes observed in low-prioritization groups would be comparable to those of other high-risk, high-intensity cohorts, which currently receive advanced support as a matter of standard health care policy, such as dialysis patients. To model potential admissions to ICU during a pandemic, all patients aged ≥16 years admitted to a Victorian ICU between the 1 st July, 2007 and the 30 th June, 2018 were included. Exclusion criteria were elective surgery, palliative care, or organ donation as reason for admission, as these patients would be excluded from triage considerations.

Recurrent hospitalisations were included, to best mirror a "pandemic event" at a specific J o u r n a l P r e -p r o o f time, which may have involved readmitted patients at that time point. We recorded demographic data including age, sex, diagnosis (defined by Acute Physiology and Chronic Health Evaluation [APACHE] III-j diagnosis codes), medical treatment limitation order, and illness severity scores (APACHE II and III-j scores, 18 and probability of death derived from the Australian and New Zealand Risk of Death [ANZROD]). 19 We only included data for those patients ultimately admitted to ICU, as distinct from patients considered for ICU admission.

The maximum SOFA score in the first 24 hours of admission to ICU was calculated, based on dysfunction in the six relevant organ systems (respiratory, cardiovascular, renal, neurological, hepatic and haematological) consistent with past definitions. 9 We categorised five groups of patients, who might be differentially prioritised for ICU admission using previously published pandemic protocols, based on age or severe comorbidities, or acute illness severity defined by degree of organ dysfunction (definitions in Supplementary Table   1 ). 6, 8 Consistent with prior pandemic protocols, three groups potentially considered likely to receive low prioritization for ICU admission were those with 1) age ≥85 years or one or more of the following comorbidities: dementia, chronic cardiovascular disease, chronic respiratory disease, metastatic cancer, hepatic failure, or severe immune suppressive disease; or 2) Severe organ dysfunction (SOFA score ≥12); or 3) Very low illness severity SOFA score = 0 (no organ failure). The medium ICU-prioritization group was defined as those with SOFA score 8-11 (intermediate organ dysfunction); and the high ICUprioritization group was defined as those with SOFA score 1-7 (mild organ dysfunction).

The primary outcome considered was long-term survival. Additional outcomes examined were in-hospital mortality, length of stay in ICU and in hospital, and ICU bed-day Cox regression analyses was performed, adjusting for site as a random effect, age, admission diagnosis, admission after medical emergency response, treatment limitations on ICU presentation, cardiac arrest occurring in hospital, and ICU setting (regional, metropolitan or tertiary). A two-sided p-value of 0.05 was used to indicate statistical significance.

After excluding elective surgical patients and those with missing SOFA or outcome data, there were 159,533 hospital episodes over the study period, which included one or more Table 3) .

Patient ages were similar in the severe SOFA score ≥12, intermediate SOFA score [8] [9] [10] [11] and mild organ dysfunction SOFA 1-7 score groups, but older in the severe comorbidity or older cohort, and younger in the SOFA score = 0 cohort ( Table 1 ). Use of invasive mechanical ventilation and renal replacement therapy was more prevalent in those with highest SOFA scores, but similar between the elderly or severe comorbidity group and those with mild organ dysfunction (SOFA score 1-7).

Hospital mortality (56%) was greatest for patients with a SOFA score ≥12 (Supplementary Figure 2) . In the elderly or comorbidity group who would receive triagebased low ICU-prioritization, in hospital mortality was 22% and lower than in the 28% mortality seen in those with intermediate organ dysfunction (SOFA score 8-11) ( Table 2 ). In all groups, younger patients had lower in-hospital and long-term mortality rates. (Table 3 Survival data to 5 years was available for 28740 patients in total, including 3296 patients with age ≥85 or one or more severe comorbidities and 332 patients with SOFA score ≥12. Of these, 1093 patients in the elderly/severe comorbidity group (33%, 95% CI 32% -34%) and 86 patients with SOFA score ≥12 (26%, 95% CI 24% -28%) were alive at 5 years. A further 290 patients combined from these groups had 10-year survival data, with 63 (22%, 95% CI 17% -27%) alive at 10 years (Figure 1, 2) . 64/170 patients aged < 55 years (Table 4 ).

ICU bed-day usage varied substantially by group, with the greatest proportion (55%) occupied by admissions in the mild organ dysfunction SOFA score category 1-7, and 27% occupied by the three groups of low prioritization patients (3% by patients with severe organ dysfunction SOFA score ≥12, 2% with no organ dysfunction SOFA score = 0, and 22% by elderly/severe comorbidity patients) (Figure 3, Supplementary Table 4 ). Elderly or comorbidity patient admissions had similar length of stay in ICU to the highest prioritization group (SOFA score 1-7) ( Table 2) . Non-survivors in all low-prioritization categories had shorter ICU lengths of stay than non-survivors from medium or high-prioritization categories.

In this retrospective population-based cohort study, we found that 33% of low priority admissions based on SOFA score or advanced age or high-comorbidity were still alive at five years, and 22% were alive at 10 years. Their in-hospital mortality was also less than the mortality of admissions with a SOFA score of 8-11. Patient admissions with severe or absent J o u r n a l P r e -p r o o f organ dysfunction only accounted for 5% of all ICU bed-days during the study period, with a further 22% of bed-days occupied by patients with advanced age or high-comorbidity.

Limited prior literature has assessed the appropriateness of SOFA scoring for those patients who might need to be triaged to ICU during a pandemic, regardless of whether they present with viral respiratory critical illness or with any other condition deemed to require ICU admission. However, recently concerns have been raised relating to subjectivity in aspects of the scoring system and variability in performance in different disease states. 11 Whether SOFA scores at ICU admission robustly correlate with outcome from patients admitted to ICU during a COVID-19 pandemic is at present not well understood; however early reports describe comparatively low SOFA scores at admission in critically ill COVID-19 patients 15 and provide no data on non-COVID-19 patients admitted to ICU during such time. A prior Australian study suggested that utilisation of the NSW and Ottawa protocols could increase ICU bed availability by 23% and 53% at admission respectively. 10 Our results build on these findings by showing that based on implementation of these recommended triage guidelines, bed-availability in Victoria ICUs could be increased by one-quarter. However, this would be at the expense of not admitting many patients who have medium and long-term survival comparable to other high-risk patient groups offered costly organ support therapies, such as chronic hemodialysis.

The long-term outcome of high-risk low priority patients in our study has to be considered in the context of other conditions, which are widely agreed to justify organ support treatment at high cost likely exceeding that of 15 days in ICU. For example, a Canadian cohort of 7841 dialysis patients of equivalent age (60-69 years) had a 10-year J o u r n a l P r e -p r o o f survival of 24%. Patients in our study with a SOFA score ≥12 and a median age of 62 years had 10-year survival of 20%. Our study cohort with either a severe comorbidity or older age (median age 72 years) had a 10-year survival (22%). This survival was significantly greater than for Canadian patients of equivalent age started on chronic dialysis (6% of men and 8% of women aged ≥70 years surviving at 10 years). 20 Five-year survival was also comparable:

27% of men and 30% of women aged ≥70 years commenced on dialysis are alive at 5 years vs. 33% of our study patients with severe comorbidity or older age. Overall, these data suggest comparable outcomes with a common, intensive organ-support intervention deemed acceptable in a developed healthcare setting, with annual US Medicare expenditure averaging $90,000 per patient. 21 Our findings reinforce recent concerns raised about SOFA scoring. 12, 22 Unfortunately, there are limited proposed alternative triage models with sufficient detail for implementation. 13, 23 The National Institute for Health and Care Excellence in the United Kingdom has recommended the Clinical Frailty Scale (CFS) be used for this purpose, with a CFS cut off of ≥5 ("mild frailty") in patients aged ≥65 years. 24 We have previously shown, however, that only a weak association exists between mortality and such frailty in critically ill patients with pneumonia, although there are data linking frailty with overall poorer outcomes after ICU admission, particularly in older patients. [25] [26] [27] Some jurisdictions have advocated for a combination of frailty, SOFA scoring, comorbid disease, and age in COVID triage decisions. 28 Other consensus groups have similarly recommended combining premorbid performance status, comorbidities, and organ failures in prioritising ICU resource allocation. 29 Further research is thus required to examine potential long-term survival and bed-days needs in different triage categories of patients incorporating these additional aspects of priority assessment.

This study implies that a significant proportion of low-priority patients, based on high level of organ dysfunction, or advanced age or severe comorbidity, have long-term survival compared to that of other high-intensity organ support therapy such as dialysis. Short lengths of stay were observed for admissions associated with mortality in these groups, implying that a large reduction in ICU bed-days "wasted" on patients who would ultimately go on to die is not realised by such a low-prioritization strategy. Finally, our findings imply that a more complex assessment of ICU admission candidates, which might involve a risk score based on a combination of frailty, age, comorbidities, organ-dysfunction and admission diagnosis is needed to inform triage decisions.

Strengths of this study include the reporting of long-term follow up data, providing a novel perspective on patient survival at different SOFA thresholds or older age or comorbidities beyond the index hospitalisation. The database used was comprehensive and large in scale, covering the majority of the Victorian population. This study also captured 11 years of ICU admissions, including the inter-pandemic period between the 2009 H1N1 influenza and current COVID-19 pandemic, thus reflecting contemporary ICU admission practices in a modern healthcare setting under normal conditions of resource constraint. Our patient population, therefore, is likely reflective of those patients who would be subject to triage (and potential exclusion from ICU) under pandemic-induced increases in ICU demand.

Conversely, ICU referral and admission patterns may change during a pandemic. Thus, repeating our study in a health-care setting experiencing resource exhaustion would be J o u r n a l P r e -p r o o f important. Future research could also seek to repeat this investigation in a population of all hospital patients being considered for ICU, rather than those already admitted. Availability of illness severity and outcome data would, however, be challenging in such a study design.

We were also unable to estimate what the outcomes would have been for patients not admitted to ICU. A minority of patients were unable to be linked to the VAED database, thus follow up data for these patients were unavailable. Overall, however, magnitude of differences between missing and included patients was small. We were not able to measure the impact of deaths recorded outside of Victoria, although we note that interstate and overseas migration during the study period affected less than 3% of the resident population (and < 1% of the population aged ≥ 50 years). 30 We were not able to account for potential differences in treatment between cohorts after hospital discharge, nor adjust for socioeconomic factors influencing survival. We did not include patients admitted to private hospitals, nor can we account for potential changes in ICU practice over the study period.

We were also unable to calculate repeated SOFA scores during the patients' course in ICU, relevant to some of the triage policies examined, which advocate for reassessment during the patient's stay in ICU. Literature exists, however, challenging the utility of interim SOFA score reviews. 31 In common with the triage policies being examined, we chose to analyse patients aged ≥85 years and those with severe comorbidities grouped within the same cohort, although long-term survival is clearly affected by advanced age at presentation.

Finally, repeated admissions affected 20% of our cohort; however we chose to analyse data at admission level (rather than discrete patients) in order not to progressively exclude previously ICU-admitted patients over the study period. This approach would have resulted in biasing our admitted cohort over time in terms of triage criteria assessment. 

Orange -Low prioritization group "No organ dysfunction" (SOFA score 0) Blue -High prioritization group "Mild organ dysfunction" (SOFA score 1-7) Magenta -Medium prioritization group "Intermediate organ dysfunction" (SOFA score 8-11) Grey -Low prioritization group "Severe organ dysfunction" (SOFA score ≥12) Green -Low prioritization group "Elderly/severe comorbidity patients" 

The Italian health system and the COVID-19 challenge. Lancet Public Health. 2020. 2. The Extraordinary Decisions Facing Italian Doctors

Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data

The severe acute respiratory syndrome

Critical care services and 2009 H1N1 influenza in Australia and New Zealand

Development of a triage protocol for critical care during an influenza pandemic

Concept of operations for triage of mechanical ventilation in an epidemic

Influenza pandemic -providing critical care. Policy Directive PD2010_028. Sydney: NSW Health

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

A multicentre evaluation of two intensive care unit triage protocols for use in an influenza pandemic

Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians

Managing ICU surge during the COVID-19 crisis: rapid guidelines

ANZICS guiding principles for complex decision making during the COVID-19 pandemic

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective

Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic

Intensive Care Resources and Activity in Australia and New Zealand, Adult Patient Database: activity report

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults

Risk prediction of hospital mortality for adult patients admitted to Australian and New Zealand intensive care units: development and validation of the Australian and New Zealand Risk of Death model

Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort

USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Fair Allocation of Scarce Medical Resources in the Time of Covid-19

The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (>/= 80 years)

Frailty in very old critically ill patients in Australia and New Zealand: a population-based cohort study

Frailty and outcomes from pneumonia in critical illness: a population-based cohort study

Admission decisions to intensive care units in the context of the major COVID-19 outbreak: local guidance from the COVID-19 Paris-region area

Adult ICU Triage During the Coronavirus Disease 2019 Pandemic: Who Will Live and Who Will Die? Recommendations to Improve Survival

An assessment of the validity of SOFA score based triage in H1N1 critically ill patients during an influenza pandemic

median (IQR) All data are numbers of admissions

All variables were significant, p < 0.001 J o u r n a l P r e -p r o o f